New remote non-invasive monitoring solutions for ensuring the health of mothers and babies before and after birth

Akronym

Newlife

Bidragets beskrivning

There is increasing focus on the well being of mothers and babies, both before and after delivery and early detection of pathologies to prevent mother and perinatal morbidity and mortality. The overall well being of mothers also has longer term impact: women who remain healthy during pregnancy and after birth are more likely to stay healthy later in life and have better birth outcomes, also influencing the infancy, childhood and adulthood of their children. NewLife project will develop new remote non-invasive monitoring solutions for ensuring the health of mothers and babies before and after birth. The target is to develop emerging non-invasive methods for gathering vital data and analysing it with advanced AI/ML methods, to be able to secure life in its most vulnerable phase. For clinical acceptance, the developed solutions need to be well integrated to the clinical workflows, with proper data integration, security, safety, and medical qualification. The technologies and solutions developed are demonstrated in five use cases for both hospitals and personalized monitoring in home environments: 1) Pregnancy & parent companion, 2) Smart garment for monitoring of pregnancies & complications, 3) Fetal monitoring patch for high-risk pregnancies, 4) Newborn monitoring with smart clothes, and 5) Newborn monitoring -well being in bed. With the developed solutions, NewLife project will contribute to the disruption of the health care models: by focusing on preventive actions rather than treating diseases, and moving healthcare from hospitals to home.
Visa mer

Startår

2023

Slutår

2025

Beviljade finansiering

498 850.63 €
Participant
FUJITSU FINLAND OY
339 500 €
Participant
KIPUWEX OY
220 500 €
Participant
PRECORDIOR OY
286 406.25 €
Participant
BENELI AB (SE)
56 100 €
Participant
Polar Electro Europe AG, Fleurier Branch (CH)
Participant
Rekonas GmbH (CH)
Participant
SENCURE B.V. (NL)
241 151.25 €
Participant
TEIIMO GMBH (DE)
375 862.5 €
Participant
Zoundream AG (CH)
Participant
Cuviva AB (SE)
477 600 €
Participant
MOMM DIAGNOSTICS GMBH (CH)
Participant
AMS INTERNATIONAL AG (CH)
Participant
NANOLEQ GMBH (CH)
Participant
Insel Gruppe AG (CH)
Participant
KNOWL SOLUTIONS B.V. (NL)
294 750 €
Participant
AMS SENSORS GERMANY GMBH (DE)
283 784 €
Participant
BOSTON SCIENTIFIC LIMITED (IE)
62 125 €
Participant
NIRX MEDIZINTECHNIK GMBH (DE)
361 125 €
Participant
NOLDUS INFORMATION TECHNOLOGY BV (NL)
186 562.5 €
Participant
RISE RESEARCH INSTITUTES OF SWEDEN AB (SE)
263 038.02 €
Participant
PHILIPS MEDIZIN SYSTEME BOBLINGEN GMBH (DE)
214 000 €
Participant
CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT (CH)
Participant
UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK (IE)
151 949.44 €
Participant
TECHNISCHE UNIVERSITEIT EINDHOVEN (NL)
439 538.31 €
Participant
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE)
629 555.06 €
Participant
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL)
384 464.06 €
Participant
PHILIPS ELECTRONICS NEDERLAND B.V. (NL)
681 727.25 €
Coordinator

Beviljat belopp

6 162 183 €

Finansiär

Europeiska unionen

Typ av finansiering

HORIZON JU Innovation Actions

Ramprogram

Horizon Europe (HORIZON)

Utlysning

Programdel
Digital, Industry and Space (11704)
Key Digital Technologies (11706)
Tema
HORIZON-KDT-JU-2021-1-IA (HORIZON-KDT-JU-2021-1-IA)
Utlysnings ID
HORIZON-KDT-JU-2021-1-IA

Övriga uppgifter

Finansieringsbeslutets nummer

101095792